Research from Water Tower Research, Water Tower Research

Water Tower Research

Water Tower Research is a leading equity research firm that provides research on micro, small and mid cap companies.

Water Tower Research was founded by Wall Street veterans after witnessing a fundamental shift in the investment research industry with the result being a declining knowledge base among investors, a lack of awareness and a shrinking pool of fundamental research being conducted on companies across the small-cap and micro-cap spectrum. The same issues are now increasingly occurring in the mid-cap space. This sea change within the investment community is impacting not only the companies themselves but also current shareholders and potential investors. With significantly less active sell-side sponsorship by Wall Street, a substantial information gap has developed between companies and various constituents in the financial community. The net result is fewer channels for insight and information to flow between companies and investors.

Research from Water Tower Research

Equity Research Firm

Equity Bottom-Up

<ul><li>The acquisition focuses on LoveBiome’s P84 product, an activation formula that stimulates the body’s natural gut peptide production to regulate, repair, and restore digestive health, which is a more robust, comprehensive approach that uplevels the probiotic supplementation discussion.</li><li>The gut microbiome market, estimated at $14 billion and projected to reach $32 billion over the next several years, represents a significant new growth category for LifeVantage, complementing its current focus on activation-based wellness.</li><li>P84 aligns with LifeVantage’s MindBody GLP-1 System, expanding the company’s reach into the fast-growing gut-brain connection market.</li></ul>

The acquisition focuses on LoveBiome’s P84 product, an activation formula that stimulates the body’s natural gut peptide production to regulate, repair, and restore digestive health, which is a more robust, comprehensive approach that uplevels the probiotic supplementation discussion.The gut microbiome market, estimated at $14 billion and projected to reach $32 billion over the next several years, represents a significant new growth category for LifeVantage, complementing its current focus on activation-based wellness.P84 aligns with LifeVantage’s MindBody GLP-1 System, expanding the company’s reach into the fast-growing gut-brain connection market.

LifeVantage Corporation: WTR Small-Cap Spotlight Recap

Lifevantage

LifeVantage Corporation: WTR Small-Cap Spotlight Recap